| RS2537449848 |
NSMCE2
|
Health Risk |
Pathogenic |
— |
| RS2537450220 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS2537450886 |
SYNGAP1
|
Health Risk |
Likely pathogenic |
SYNGAP1-related disorder, SYNGAP1-related disorder |
| RS2537451492 |
SYNGAP1
|
Health Risk |
Pathogenic |
— |
| RS2537452061 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS2537452533 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS2537453071 |
SYNGAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Intellectual disability |
| RS2537453391 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS2537453727 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS2537453921 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS2537459268 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS2537472769 |
PLEC
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 5B, with muscular dystrophy |
| RS2537475263 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS2537475410 |
SYNGAP1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS2537475927 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS2537480235 |
TONSL
|
Health Risk |
Pathogenic |
— |
| RS2537481541 |
TONSL
|
Health Risk |
Pathogenic |
— |
| RS2537483665 |
TONSL
|
Health Risk |
Likely pathogenic |
Sponastrime dysplasia, Sponastrime dysplasia |
| RS2537487155 |
TONSL
|
Health Risk |
Pathogenic |
— |
| RS2537488321 |
TONSL
|
Health Risk |
Pathogenic |
— |
| RS2537499869 |
TONSL
|
Health Risk |
Likely pathogenic |
Sponastrime dysplasia, Sponastrime dysplasia |
| RS2537502482 |
TONSL
|
Health Risk |
Pathogenic |
— |
| RS2537506170 |
TONSL
|
Health Risk |
Pathogenic |
— |
| RS2537506917 |
TONSL
|
Health Risk |
Likely pathogenic |
TONSL-related disorder, TONSL-related disorder |
| RS2537508009 |
TONSL
|
Health Risk |
Pathogenic/Likely pathogenic |
TONSL-related disorder, TONSL-related disorder |
| RS2537511560 |
TONSL
|
Health Risk |
Likely pathogenic |
— |
| RS2537511614 |
TONSL
|
Health Risk |
Pathogenic |
— |
| RS2537512231 |
TONSL
|
Health Risk |
Likely pathogenic |
— |
| RS2537516964 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2537517002 |
VPS13A
|
Health Risk |
Pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS2537519119 |
PLEC
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS2537521414 |
ZFTRAF1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia and gross motor and speech delay, Neurodevelopmental disorder with hypotonia and gross motor and speech delay |
| RS2537521721 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2537521774 |
ZFTRAF1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia and gross motor and speech delay, Neurodevelopmental disorder with hypotonia and gross motor and speech delay |
| RS2537521833 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2537530774 |
ZFTRAF1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia and gross motor and speech delay, Neurodevelopmental disorder with hypotonia and gross motor and speech delay |
| RS2537536904 |
FREM1
|
Health Risk |
Likely pathogenic |
Oculotrichoanal syndrome, Oculotrichoanal syndrome |
| RS2537538964 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2537539083 |
KIF1A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 30, Neuropathy |
| RS2537558012 |
DOCK8
|
Health Risk |
Likely pathogenic |
DOCK8-related disorder, DOCK8-related disorder |
| RS2537560344 |
DOCK8
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS2537569171 |
TG
|
Health Risk |
Pathogenic |
— |
| RS2537570064 |
TG
|
Health Risk |
Pathogenic |
— |
| RS2537570239 |
SNX14
|
Health Risk |
Likely pathogenic |
Autosomal recessive spinocerebellar ataxia 20, Autosomal recessive spinocerebellar ataxia 20 |
| RS2537586034 |
MPDZ
|
Health Risk |
Pathogenic |
— |
| RS2537589468 |
VARS1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with microcephaly, seizures |
| RS2537595474 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS2537595478 |
VPS13A
|
Health Risk |
Pathogenic/Likely pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS2537596049 |
VPS13A
|
Health Risk |
Likely pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS2537596293 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS2537599374 |
VARS1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with microcephaly, seizures |
| RS2537602940 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2537603710 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS2537629962 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2537630096 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2537640975 |
ARID1B
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS2537641323 |
ARID1B
|
Health Risk |
Likely pathogenic |
Global developmental delay, Global developmental delay |
| RS2537641958 |
ARID1B
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS2537652626 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2537666515 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2537667918 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2537669686 |
BBS9
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 9, Bardet-Biedl syndrome 9 |
| RS2537669983 |
BBS9
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2537670864 |
BBS9
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 9, Bardet-Biedl syndrome 9 |
| RS2537702005 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2537702433 |
FREM1
|
Health Risk |
Pathogenic |
BNAR syndrome, BNAR syndrome |
| RS2537710137 |
AGTPBP1
|
Health Risk |
Likely pathogenic |
Neurodegeneration, childhood-onset |
| RS2537713123 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS2537713398 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2537713873 |
DOCK8
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS2537716968 |
TG
|
Health Risk |
Pathogenic |
— |
| RS2537720984 |
VPS13A
|
Health Risk |
Likely pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS2537729498 |
KIF1A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 30, Neuropathy |
| RS2537729643 |
PLEC
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex with nail dystrophy, Epidermolysis bullosa simplex with nail dystrophy |
| RS2537735975 |
TG
|
Health Risk |
Likely pathogenic |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS2537770319 |
DPYS
|
Health Risk |
Pathogenic |
— |
| RS2537770775 |
DPYS
|
Health Risk |
Likely pathogenic |
Dihydropyrimidinase deficiency, Dihydropyrimidinase deficiency |
| RS2537771120 |
MNX1
|
Health Risk |
Likely pathogenic |
MNX1-related disorder, Abnormality of the vertebral column |
| RS2537773911 |
MNX1
|
Health Risk |
Likely pathogenic |
MNX1-related disorder, MNX1-related disorder |
| RS2537774020 |
MNX1
|
Health Risk |
Pathogenic |
— |
| RS2537774041 |
MNX1
|
Health Risk |
Likely pathogenic |
— |
| RS2537775651 |
NTHL1
|
Health Risk |
Pathogenic |
— |
| RS2537779184 |
PLEC
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa simplex with nail dystrophy, Epidermolysis bullosa simplex with nail dystrophy |
| RS2537780039 |
MNX1
|
Health Risk |
Pathogenic |
— |
| RS2537780127 |
MNX1
|
Health Risk |
Pathogenic/Likely pathogenic |
MNX1-related disorder, MNX1-related disorder |
| RS2537780168 |
MNX1
|
Health Risk |
Pathogenic |
Currarino triad, Currarino triad |
| RS2537780831 |
MNX1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2537781329 |
MNX1
|
Health Risk |
Pathogenic |
Currarino triad, Currarino triad |
| RS2537781362 |
MNX1
|
Health Risk |
Pathogenic |
— |
| RS2537781555 |
MNX1
|
Health Risk |
Pathogenic |
— |
| RS2537803859 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2537804052 |
VPS13A
|
Health Risk |
Pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS2537812623 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2537813053 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2537813639 |
DNAAF11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 19, Primary ciliary dyskinesia 19 |
| RS2537814042 |
PLEC
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 5B, with muscular dystrophy |
| RS2537814830 |
TG
|
Health Risk |
Pathogenic |
— |
| RS2537816225 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2537816345 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2537816494 |
VPS13A
|
Health Risk |
Pathogenic |
— |